# Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine

> **NCT02948933** · — · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 30000 (actual)

## Conditions studied

- Dengue Fever
- Dengue Hemorrhagic Fever

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02948933
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-14
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 30000 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02948933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02948933, "Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02948933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*